Correction: Arena Hit Hard After Initial FDA Findings (ARNA)

A previous Benzinga article reported erroneously that the FDA had already ruled on the Arena Pharmaceuticals ARNA drug for weight loss. The ruling is not until Thursday. The initial findings were released, in which the FDA said there were three noteworthy safety issues" found in the testing of rats. Shares are down sharply on this news. Benzinga regrets this error. You Can't Afford Miss To Out On These Money Making Trading Ideas.